Digital Biomarkers Market Size

Digital Biomarkers Market Future Prospects

The global digital biomarkers market size in 2024 is USD 3.0 billion, and it is expected to advance at a CAGR of 29.0% during 2025–2032, to reach USD 23.5 billion by 2032.

The high prevalence of chronic diseases, as well as the technological improvements in digital healthcare systems, is driving the market expansion. During the COVID-19 pandemic, the integration of AI in wearable devices, emergence of mHealth apps, and growth in the trend of remote patient monitoring and telemedicine devices all contributed to the growth of the market. Digital biomarkers are importance indicators for disease management as they yield important data about patients that helps in informed clinical decision-making.

Current times are experiencing a manifold rise in the incidence of severe illnesses due to the swift industrialization and urbanization, which generate huge amounts of pollution and lead to altered lifestyles. This, in turn, deteriorates the living conditions of people with improper sanitation, lack of clean water, and a worsening air quality.

The surging geriatric population is also driving the demand for digital biomarkers for tracking body temperature and other vital signs and providing transparency in monitoring activity for remote health management. Additionally, the rising focus on patient safety and comfort drives the demand for remote patient monitoring systems, thereby propelling the market as they enhance care access, efficiency, and outcomes.

At the same time, with the increasing use of smartphones, smartwatches, and wearable medical bracelets and fitness trackers, health is being tracked through integrated accelerometers and motion detectors. The data they send to the doctor over the internet helps in a better delivery of care and improved patient outcomes.